Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy

Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy

Colorectal cancer (CRC) ranks as second most common cause of cancer-related deaths. The CRC management considerably improved in recent years, especially due to biological therapies such as bevacizumab. The lack of predictive or prognostic biomarkers remains one of the major disadvantages of using be...

Full description

Bibliographic Details
Main Authors: Diana Cornelia Moisuc, Daniela Constantinescu, Mihai Vasile Marinca, Bogdan Gafton, Mariana Pavel-Tanasa, Petru Cianga
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
cyclophilin A
prognostic factor
bevacizumab
chemotherapy
metastatic colorectal cancer
Online Access:https://www.mdpi.com/2072-6694/16/2/385

Similar Items

Similar Items